Peptavo is Accredited for 20 CME hours.Peptavo is Jointly Accredited for 20 CME hours. Learn more about accreditation
PEPTAVO
The Stack Source LLC1908 E 11th Street Austin, TX 78702support@peptavo.com(512) 827-8158DBA: Peptavo
Peptavo is Accredited for 20 CME hours.Peptavo is Jointly Accredited for 20 CME hours. Learn more about accreditation
Get volume discounts if you are getting 3 or more clinicians certified
Book a Call
Yes. A registered nurse can administer a peptide injection on a valid, patient-specific order from a physician, NP, or PA who has examined the patient. An RN cannot choose the peptide, set the dose, rely on a generic standing order for elective therapy, send vials home, or touch a research use only product.
Yes. Registered nurses can administer peptides, including peptide injections, in every state, because giving a prescribed injection is a core nursing act, and none of the nurse practice acts or board statements we reviewed treat a lawfully sourced peptide differently from any other prescription drug given on a valid order.
What an RN cannot do is the part that decides whether a peptide program is lawful. An RN cannot prescribe, cannot choose which peptide a patient gets or how much, and in most states cannot act on a generic standing order for elective wellness therapy. The order has to come from a physician, nurse practitioner, or physician assistant who has evaluated that patient. This guide covers what boards of nursing have said about each piece, then the practical questions clinics run into: reconstitution, take-home vials, office stock, and research peptides.
Status as of October 23, 2026. We found no state board of nursing statement written specifically about RNs administering compounded peptides. The rules below come from board statements on IV hydration, med spa, and aesthetic injections, which apply the same nurse practice act provisions to the same kind of elective, cash-pay therapy, and from the boards that have addressed research peptides directly. For who holds prescriptive authority, see our hub on who can prescribe peptides.
The line every board we reviewed draws is between the medical decision and the nursing act. Prescribing means assessing whether a patient needs a drug and ordering it, and the North Dakota Board of Nursing puts the dosing piece plainly: "Determining dosages is an element of prescribing" (NDBON Nursing Practice FAQ). Administering means carrying out that order safely.
| The prescriber (MD, DO, NP, or PA) | The RN |
|---|---|
| Examines the patient and establishes the relationship | Collects history and vitals that inform the prescriber's exam |
| Diagnoses and decides peptide therapy is indicated | Verifies the order and screens for contraindications before each dose |
| Chooses the product, dose, route, frequency, and duration | Gives the injection exactly as ordered |
| Changes the plan after re-evaluating the patient | Reports response, side effects, and changes in condition |
| Owns the treatment plan | Teaches the patient, documents the care, and holds a dose that looks unsafe |
Virginia's Department of Health Professions, in guidance covering its Boards of Medicine, Nursing, and Pharmacy that names "GLP-1, GIP, or other peptides" among the services they are addressing, say RNs "may administer IV fluids and injections only pursuant to a valid order from a licensed prescriber" and may not diagnose, recommend compounded drugs, or "determine dosage, route, or frequency" (Virginia DHP, IV Hydration Clinics and Med Spas). Ohio's board says a licensed nurse "should not independently select the medication or dosage to be administered" (Ohio Board of Nursing interpretive guideline).
That last point catches peptide programs that let a nurse titrate. A protocol that says "increase by one step every two weeks if tolerated" leaves the RN making a dosing decision. In aesthetic practice, North Dakota requires the prescriber to perform and document a new evaluation before any change in product or dose, and a peptide program should assume the same.
Every board we reviewed that has addressed elective therapy requires a prescriber to evaluate the patient before the RN gives anything. Georgia's Board of Nursing says the RN may administer only with "a valid order/prescription and a completed history and physical performed by the physician, NP, or PA," and that an RN who is the only licensed professional "interacting with, evaluating, and treating the patient is practicing beyond the RN and LPN's scope of practice" (Georgia BON, IV Hydration Position Statement). Mississippi uses nearly the same words (MSBN Position Statement).
California reaches the same result through its prescribing law. Prescribing or furnishing a dangerous drug without "an appropriate prior examination and a medical indication" is unprofessional conduct (Cal. Bus. & Prof. Code 2242), and the Board of Registered Nursing tells med spas that patients "must be examined by a physician or an advanced practitioner, such as a nurse, or a physician assistant, before treatments are administered." Our California guide covers the rest of the state's rules.
The exam can usually happen by telehealth, but not by form. California's statute allows an asynchronous exam where the standard of care is met. North Dakota accepts telehealth and says photos are not enough. Virginia requires real-time interaction with the prescriber and says "sole use of questionnaires is insufficient."
Standing orders are where most RN-run wellness models fail. Georgia and Oklahoma both state that standing orders "are not an appropriate substitute" for an individualized order and a history and physical (Oklahoma BON Guideline P-24, revised May 2026), and Mississippi calls them "not acceptable substitutes." Virginia goes further: drugs may not be administered "pursuant to protocols or standing orders" in these settings, and protocols "cannot replace individualized medical evaluation for elective med spa or IV hydration services."
A standing order still has a place inside a properly built program. Once a prescriber has examined the patient and written a peptide order, standing orders for the emergencies that order could cause, such as anaphylaxis, are good practice. What they cannot do is put a new patient on a peptide.
How closely the prescriber must supervise varies more than anything else on this list.
| State | What the rule says |
|---|---|
| Washington | The RN administers under the "general direction" of an authorized practitioner (WABON Advisory Opinion), and for injections such as neuromodulators the nursing rules do not require that practitioner on site (WABON FAQ) |
| Virginia | Someone licensed to perform the procedure and manage emergencies should always be on site, and the medical director should be immediately available by phone or text |
| Ohio | Cosmetic injections belong in "a supportive clinical environment" with monitoring and complication management; salons, malls, and homes may not qualify |
| Texas | For elective IV therapy outside a physician's office, a physician may delegate administration to an RN "acting under adequate physician supervision" (Tex. Occ. Code 172.051, effective September 2025). The statute covers IV therapy, not subcutaneous injections |
Mobile and in-home peptide services deserve the most caution. They are the setting boards single out, and the RN is often the only clinician present.
Three practical questions come up in nearly every clinic that hires RNs to run peptide visits.
Reconstituting a vial. Most compounded peptides arrive lyophilized. Virginia law authorizes physicians, APRNs, and PAs to mix, dilute, and reconstitute, and lets them delegate it to trained, supervised staff working to USP standards. An RN who reconstitutes should follow the pharmacy's labeled directions and the clinic's written aseptic procedure, and should not add anything the order does not call for. Combining products in one syringe can count as compounding.
Whose vial it is. A product a 503A pharmacy compounded for a named patient belongs to that patient. Virginia says it "cannot be administered to other persons," which rules out using one patient's vial to treat the next. Clinics that want shared supply buy office stock from a registered 503B outsourcing facility; our guide to 503A and 503B pharmacies explains what each may supply.
Sending vials home. Handing a patient a prescription drug to use later is generally dispensing, which is not within RN scope. Virginia says so directly, and North Dakota treats giving out samples as dispensing. The lawful routes are a pharmacy dispensing to the patient, or a prescriber with the required dispensing license. The RN's part is teaching the patient to self-inject, which is squarely nursing.
No order makes a research use only vial lawful to administer. A joint statement from the Mississippi Board of Nursing, Board of Pharmacy, and State Board of Medical Licensure, issued August 19, 2026, says "under no circumstances is it permissible for a healthcare provider to compound, administer, or dispense a non FDA approved or research-grade peptide to a patient," and that consent forms calling a product research grade "do not mitigate or eliminate a provider's professional or legal liability" (Mississippi joint statement). Virginia's boards say a product labeled for research purposes is unlawful for an IV hydration clinic or med spa even to possess, "regardless of patient 'consent.'"
The nurse carries this risk personally. An RN who gives an unlawful product cannot point to the prescriber's order, because each nurse is accountable for the care that nurse provides. Our guide to research use only peptides explains why no state treats them as prescription drugs.
Yes, on a valid, patient-specific order from a physician, NP, or PA who has examined the patient. Giving the injection is nursing practice; choosing the peptide and the dose is prescribing.
No. RNs have no prescriptive authority in any state. Georgia and North Dakota say diagnosing and setting treatment are outside RN scope, and Virginia adds that an RN may not recommend a compounded drug or set its dose. An RN who wants to prescribe needs an advanced practice license; see whether nurse practitioners can prescribe peptides.
Not for elective wellness therapy in the states that have addressed it. Georgia, Mississippi, Oklahoma, and Virginia all hold that a standing order does not replace the prescriber's individual evaluation and order.
No. A prescriber has to examine each patient and own the treatment plan. In California, the clinic itself must also be majority owned by physicians, with any remaining share held by certain other licensed practitioners.
It depends on the state. LPNs generally administer under the supervision of an RN or prescriber, and Virginia says unlicensed staff in med spa settings may not give injections at all. Check the specific nurse practice act and medical board delegation rules before assigning the task.
No. Authority to administer comes from the RN license and a valid order. Training is what makes the RN competent to do it safely, and boards expect documented competence for any new therapy. Our peptide course for nurses carries 20 ANCC contact hours, and our guide to adding peptide therapy to a practice covers staffing, consent, and documentation for the whole team.